Table 4.
Comparison of clinical manifestations and leukocyte count in the first week of invasive pulmonary aspergillosis infection.
| Group | IPA(n=43) | CAP(n=51) | Chi-squaredvalue | P value |
|---|---|---|---|---|
| Symptoms and signs | 25.7546 | < 0.0001 | ||
| Fever + wheezing and/or rhonchi | 8 | 14 | ||
| Fever + cough and/or rhonchi + hemoptysis | 5 | 18 | ||
| Fever + wheezing and/or rhonchi + hemoptysis | 26 | 6 | ||
| Other | 4 | 13 | ||
| Leukocyte count in routine blood testing | 13.892 | 0.0031 | ||
| WBC < 4.0 × 109/L | 5 | 11 | ||
| WBC 4.0–10.0 × 109/L | 5 | 13 | ||
| WBC 10.1–20.0 × 109/L | 11 | 19 | ||
| WBC >20.0 × 109/L | 22 | 8 | ||
| GM test | 51.0013 | < 0.0001 | ||
| GM < 0.5 | 6 | 9 | ||
| GM 0.5–1.5 | 22 | 3 | ||
| GM >1.5 | 10 | 0 | ||
| No GM detected | 5 | 39 |
IPA, invasive pulmonary aspergillosis; CAP, community-acquired pneumonia; WBC, white blood cells; GM, galactomannan.